Intravenous transfer of apoptotic cell-treated dendritic cells leads to immune tolerance by blocking Th17 cell activity

Immunobiology

Volumn 218, Issue 8, 2013, Pages 1069-1076

  Zhou, Fang ^a,b   Lauretti, Elisabetta ^a   di Meco, Antonio ^a   Ciric, Bogoljub ^a   Gonnella, Patricia ^a   Zhang, Guang Xian ^a   Rostami, Abdolmohamad ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Dendritic cell; EAE; Immune tolerance; Immunotherapy; Th17 cell

Indexed keywords

CD205 ANTIGEN; CD45 ANTIGEN; GALECTIN 1; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 21; INTERLEUKIN 22; LYMPHOCYTE ANTIGEN; RETINOID RELATED ORPHAN RECEPTOR GAMMA; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOTIC CELL TREATED DENDRITIC CELL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH17 CELL;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD45; APOPTOSIS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GALECTIN 1; IMMUNE TOLERANCE; IMMUNOTHERAPY; LECTINS, C-TYPE; MICE; MICE, INBRED C57BL; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; PEPTIDE FRAGMENTS; RECEPTORS, CELL SURFACE; RECEPTORS, CHEMOKINE; TH17 CELLS;

EID: 84878574076     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2013.02.003     Document Type: Article

References (48)

1. Blois S.M., Ilarregui J.M., Tometten M., Garcia M., Orsal A.S., Cordo-Russo R., Toscano M.A., Bianco G.A., Kobelt P., Handjiski B., Tirado I., Markert U.R., Klapp B.F., Poirier F., Szekeres-Bartho J., Rabinovich G.A., Arck P.C. A pivotal role for galectin-1 in fetomaternal tolerance. Nat. Med. 2007, 13:1450-1457.
2. Brereton C.F., Sutton C.E., Lalor S.J., Lavelle E.C., Mills K.H. Inhibition of ERK MAPK suppresses IL-23- and IL-1-driven IL-17 production and attenuates autoimmune disease. J. Immunol. 2009, 183:1715-1723.
3. da Costa T.B., Sardinha L.R., Larocca R., Peron J.P., Rizzo L.V. Allogeneic apoptotic thymocyte-stimulated dendritic cells expand functional regulatory T cells. Immunology 2011, 133:123-132.
4. Danese S., de la Rue S.A., Rutella S. Dendritic cells, TGF-beta, and Integrin alphavbeta8 in inflammatory bowel disease: a tolerogenic "menage a trois". Gastroenterology 2008, 134:354-355.
5. Fukaya T., Murakami R., Takagi H., Sato K., Sato Y., Otsuka H., Ohno M., Hijikata A., Ohara O., Hikida M., Malissen B., Sato K. Conditional ablation of CD205+ conventional dendritic cells impacts the regulation of T-cell immunity and homeostasis in vivo. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:11288-11293.
6. Furlan R., Cuomo C., Martino G. Animal models of multiple sclerosis. Methods Mol. Biol. 2009, 549:157-173.
7. Gilliet M., Boonstra A., Paturel C., Antonenko S., Xu X.L., Trinchieri G., O'Garra A., Liu Y.J. The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 2002, 195:953-958.
8. Glader P., Smith M.E., Malmhall C., Balder B., Sjostrand M., Qvarfordt I., Linden A. Interleukin-17-producing T-helper cells and related cytokines in human airways exposed to endotoxin. Eur. Respir. J. 2010, 36:1155-1164.
9. Gleisner M.A., Rosemblatt M., Fierro J.A., Bono M.R. Delivery of alloantigens via apoptotic cells generates dendritic cells with an immature tolerogenic phenotype. Transplant. Proc. 2011, 43:2325-2333.
10. Hadeiba H., Sato T., Habtezion A., Oderup C., Pan J., Butcher E.C. CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nat. Immunol. 2008, 9:1253-1260.
11. Hofstetter H., Gold R., Hartung H.P. Th17 cells in MS and experimental autoimmune encephalomyelitis. Int. MS J./MS Forum 2009, 16:12-18.
12. Huang H., Dawicki W., Zhang X., Town J., Gordon J.R. Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells. J. Immunol. 2010, 185:5003-5010.
13. Ilarregui J.M., Croci D.O., Bianco G.A., Toscano M.A., Salatino M., Vermeulen M.E., Geffner J.R., Rabinovich G.A. Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat. Immunol. 2009, 10:981-991.
14. Ito R., Katano I., Ida-Tanaka M., Kamisako T., Kawai K., Suemizu H., Aiso S., Ito M. Efficient xenoengraftment in severe immunodeficient NOD/Shi-scid IL2rgammanull mice is attributed to a lack of CD11c+B220+CD122+ cells. J. Immunol. 2012, 189:4313-4320.
15. Jang E., Cho S.H., Park H., Paik D.J., Kim J.M., Youn J. A positive feedback loop of IL-21 signaling provoked by homeostatic CD4+CD25- T cell expansion is essential for the development of arthritis in autoimmune K/BxN mice. J. Immunol. 2009, 182:4649-4656.
16. Jin W., Zhou X.F., Yu J., Cheng X., Sun S.C. Regulation of Th17 cell differentiation and EAE induction by MAP3K NIK. Blood 2009, 113:6603-6610.
17. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 cells. Annu. Rev. Immunol. 2009, 27:485-517.
18. Kreymborg K., Etzensperger R., Dumoutier L., Haak S., Rebollo A., Buch T., Heppner F.L., Renauld J.C., Becher B. IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis. J. Immunol. 2007, 179:8098-8104.
19. Kushwah R., Wu J., Oliver J.R., Jiang G., Zhang J., Siminovitch K.A., Hu J. Uptake of apoptotic DC converts immature DC into tolerogenic DC that induce differentiation of Foxp3+ Treg. Eur. J. Immunol. 2010, 40:1022-1035.
20. Langlois R.A., Legge K.L. Respiratory dendritic cells: mediators of tolerance and immunity. Immunol. Res. 2007, 39:128-145.
21. Li Q., Pan P.Y., Gu P., Xu D., Chen S.H. Role of immature myeloid Gr-1+ cells in the development of antitumor immunity. Cancer Res. 2004, 64:1130-1139.
22. Liang S.C., Tan X.Y., Luxenberg D.P., Karim R., Dunussi-Joannopoulos K., Collins M., Fouser L.A. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 2006, 203:2271-2279.
23. Liu R., Bai Y., Vollmer T.L., Bai X.F., Jee Y., Tang Y.Y., Campagnolo D.I., Collins M., Young D.A., La Cava A., Shi F.D. IL-21 receptor expression determines the temporal phases of experimental autoimmune encephalomyelitis. Exp. Neurol. 2008, 211:14-24.
24. Lutz M.B., Kukutsch N., Ogilvie A.L., Rossner S., Koch F., Romani N., Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 1999, 223:77-92.
25. Lutz M.B., Kurts C. Induction of peripheral CD4+ T-cell tolerance and CD8+ T-cell cross-tolerance by dendritic cells. Eur. J. Immunol. 2009, 39:2325-2330.
26. Malmberg K.J., Levitsky V., Norell H., de Matos C.T., Carlsten M., Schedvins K., Rabbani H., Moretta A., Soderstrom K., Levitskaya J., Kiessling R. IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism. J. Clin. Invest. 2002, 110:1515-1523.
27. Manel N., Unutmaz D., Littman D.R. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat. Immunol. 2008, 9:641-649.
28. Miossec P. IL-17 and Th17 cells in human inflammatory diseases. Microbes Infect. 2009, 11:625-630.
29. Nakano H., Yanagita M., Gunn M.D. CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J. Exp. Med. 2001, 194:1171-1178.
30. Nikolic T., Dingjan G.M., Leenen P.J., Hendriks R.W. A subfraction of B220(+) cells in murine bone marrow and spleen does not belong to the B cell lineage but has dendritic cell characteristics. Eur. J. Immunol. 2002, 32:686-692.
31. Perone M.J., Bertera S., Tawadrous Z.S., Shufesky W.J., Piganelli J.D., Baum L.G., Trucco M., Morelli A.E. Dendritic cells expressing transgenic galectin-1 delay onset of autoimmune diabetes in mice. J. Immunol. 2006, 177:5278-5289.
32. Segal B.M. Th17 cells in autoimmune demyelinating disease. Semin. Immunopathol. 2010, 32:71-77.
33. Shrimpton R.E., Butler M., Morel A.S., Eren E., Hue S.S., Ritter M.A. CD205 (DEC-205): a recognition receptor for apoptotic and necrotic self. Mol. Immunol. 2009, 46:1229-1239.
34. Sumpter T.L., Thomson A.W. The STATus of PD-L1 (B7-H1) on tolerogenic APCs. Eur. J. Immunol. 2011, 41:286-290.
35. Sutton C.E., Lalor S.J., Sweeney C.M., Brereton C.F., Lavelle E.C., Mills K.H. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 2009, 31:331-341.
36. Tuettenberg A., Huter E., Hubo M., Horn J., Knop J., Grimbacher B., Kroczek R.A., Stoll S., Jonuleit H. The role of ICOS in directing T cell responses: ICOS-dependent induction of T cell anergy by tolerogenic dendritic cells. J. Immunol. 2009, 182:3349-3356.
37. Vollmer T.L., Liu R., Price M., Rhodes S., La Cava A., Shi F.D. Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen. J. Immunol. 2005, 174:2696-2701.
38. Wei L., Laurence A., Elias K.M., O'Shea J.J. IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J. Biol. Chem. 2007, 282:34605-34610.
39. Weyand C.M., Younge B.R., Goronzy J.J. IFN-gamma and IL-17: the two faces of T-cell pathology in giant cell arteritis. Curr. Opin. Rheumatol. 2011, 23:43-49.
40. Xu G., Tu W., Xu C. Immunological tolerance induced by galectin-1 in rat allogeneic renal transplantation. Int. Immunopharmacol. 2010, 10:643-647.
41. Yamazaki S., Dudziak D., Heidkamp G.F., Fiorese C., Bonito A.J., Inaba K., Nussenzweig M.C., Steinman R.M. CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells. J. Immunol. 2008, 181:6923-6933.
42. Yura M., Takahashi I., Serada M., Koshio T., Nakagami K., Yuki Y., Kiyono H. Role of MOG-stimulated Th1 type "light up" (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE). J. Autoimmun. 2001, 17:17-25.
43. Zhang G.X., Kishi M., Xu H., Rostami A. Mature bone marrow-derived dendritic cells polarize Th2 response and suppress experimental autoimmune encephalomyelitis. Mult. Scler. 2002, 8:463-468.
44. Zhou F. Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation. Int. Rev. Immunol. 2009, 28:239-260.
45. Zhou F., Ciric B., Li H., Yan Y., Li K., Cullimore M., Lauretti E., Gonnella P., Zhang G.X., Rostami A. IL-10 deficiency blocks the ability of LPS to regulate expression of tolerance-related molecules on dendritic cells. Eur. J. Immunol. 2012, 42:1449-1458.
46. Zhou, F., Ciric, B., Gonnella, P., Zhang, G.X., Rostami, A. Tolerance induced by intravenous transfer of immature dendritic cells via up-regulating numbers of suppressive IL-10+ IFN-γ+ producing CD4+ T cells. Immunol. Res., 2013. [Epub ahead of print], PMID: 23292714.
47. Zhuang Y., Peng L.S., Zhao Y.L., Shi Y., Mao X.H., Guo G., Chen W., Liu X.F., Zhang J.Y., Liu T., Luo P., Yu P.W., Zou Q.M. Increased intratumoral IL-22-producing CD4(+) T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival. Cancer Immunol. Immunother. 2012, 61(11):1965-1975.
48. Zielinski C.E., Mele F., Aschenbrenner D., Jarrossay D., Ronchi F., Gattorno M., Monticelli S., Lanzavecchia A., Sallusto F. Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta. Nature 2012, 484:514-518.